@entremed.com Pages on BioPortfolio:

BioPortfolio.com - BioWeb THALOMID THALIDOMIDE ballv. lantero ...
EntreMed, Inc. Announces Commencement of Phase I Clinical Trial Of Orally-Active ... Gubish, Jr., EntreMed's Executive Vice President for Research and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Biotechnology News arthritis panzem. enmd. entrem. 2076. thalomid ...
EntreMed Reports Clinical Program Progress and Company Update ... EntreMed's MKC -1 meets primary efficacy endpoint in non-small cell lung cancer clinical ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - @entremed.com
entremed.com - BioPortfolio. ... Recent Search Terms used to find this page: entremed.com | entremed.com | EntreMed Incorporated | Entremed . ...
http://www.bioportfolio.com/search/@entremed.com.html...

Biotechnology News Burns Search
EntreMed Reports Clinical Program Progress and Company Update ROCKVILLE, Md., Nov. 12, /PRNewswire-FirstCall/ -- EntreMed, Inc. ...
http://www.bioportfolio.co.uk/Burns-news.htm...

BioPortfolio - Biocorporate Search Multiple Sclerosis
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the ...
http://www.bioportfolio.com/biocorporate/Multiple%20Sclerosi...

Biotechnology News Burns fio. schaffer. venul. xxiv. highland ...
EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference Amy Winehouse Losing Control....Once More(7 hrs ago) Bill Gates Visits Sex ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Biocorporate Search Rockville
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing next generation multi-mechanism oncology and antiinflammatory drugs that ...
http://www.bioportfolio.com/biocorporate/search/city/Rockvil...

Results from other life science and pharmaceutical sites:

BioSpace - EntreMed, Inc. News, Search Jobs, Events
EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism drugs that target disease cells directly and the blood ...
http://www.biospace.com/company_profile.aspx?CompanyId=2078...

Elan: Elan and EntreMed Execute License Agreement for Proprietary ...
Under the License Agreement and corresponding Services Agreement, Elan will manufacture EntreMed's Panzem® NCD, a NanoCrystal Technology formulation with
...
http://www.elan.com/news/2006/20060110.asp...

EntreMed, Inc. Presents Results for ENMD-1198 and Vincristine in ...
10 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory ...
http://www.biospace.com/news_story.aspx?NewsEntityId=80013...

EntreMed Reports Clinical Program Progress and Company Update
The updates were given during a podium presentation by EntreMed President & CEO, James S. Burns , and web cast at the Rodman & Renshaw 10th Annual ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

EntreMed, Inc. Presents MKC-1 Phase 2 Data at American Society of ...
Carolyn F. Sidor, MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this
...
http://www.biospace.com/news_story.aspx?NewsEntityId=98731...

EntreMed to Present at BioPartnering Europe Conference
EntreMed is actively marketing ENMD-2076 and 2ME2 for RA to prospective pharmaceutical and biotech company partners as a means to accelerate the
development ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus....

EntreMed, Inc. Reports Phase 1 PK and Preclinical Efficacy Results ...
Mark R. Bray, Ph.D., EntreMed Vice President, Research, commented on the results , "Preclinical studies with ENMD-1198 continue to highlight its significant ...
http://www.biospace.com/news_story.aspx?NewsEntityId=74846...

Entremed - Investor Relations: News
EntreMed's scientific team, including collaborators, will present 14 different abstracts covering three drug classes -- proteins, small molecules and ...
http://www.prnewswire.com/cgi-bin/micro_stories.pl?ACCT=no&T...

EntreMed Reports Clinical Program Progress and Company Update ...
EntreMed Reports Clinical Program Progress and Company Update. - ROCKVILLE, Md., Nov. 12, /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - News), ...
http://biz.yahoo.com/prnews/081112/ph45548.html?.v=1...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR ...
The data will be presented by EntreMed scientists and collaborators during the American Association for Cancer Research (AACR) Annual Meeting being held ...
http://prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.